Report Description
A recent market
intelligence report that is published by Data Insights Partner on the global
multiple sclerosis treatment market makes an
offering of in-depth analysis of segments and sub-segments in the regional and
international Multiple Sclerosis Treatment market. The research also emphasizes on the impact of restraints,
drivers, and macro indicators on the regional and global multiple
sclerosis treatment market over the short
as well as long period of time. A detailed presentation of forecast, trends,
and dollar values of global multiple sclerosis treatment market is offered. In accordance with the report, the global multiple
sclerosis treatment market is projected to
expand at a CAGR of 4% over the period
of forecast.
Market Insight, Drivers, Restraints&
Opportunity of the Market:
Multiple Sclerosis (MS) is a chronic autoimmune disease
which affects the normal communication between brain and the other parts of the
body. Particularly, this abnormality damages the membrane of the brain tissues
and spinal cords which may cause the patients to show dizziness, unstable gait,
fatigue, tremor, partial or complete loss of vision, problems with bladder
function etc. However, the symptoms of multiple sclerosis depend on the degree
of damage of the brain tissue and spinal cord tissue. However, there is no cure
for the patients who are affecting from MS- but the change of lifestyles and
medicines help the patients to manage the MS.
The global multiple sclerosis treatment market is
primarily driven by the increasing aging population and growing incidence of
multiple sclerosis patients across worldwide. Around 3 Million people have been
suffering from multiple sclerosis across worldwide- a study estimated that
around 0.2% of the total population in the UK suffered from multiple sclerosis
in 2018 and this percentage is anticipated to grow by 2% during the forecast
period.
On the contrary, the growth of the global multiple
sclerosis treatment market may be hampered by low awareness about multiple
sclerosis, low diagnosis rate of multiple sclerosis among patients and
unavailability of treatments which can completely cure multiple sclerosis among
the patients. In addition, drug recalls
due to side effects may restrain the expansion of the global multiple sclerosis
treatment market during the forecast period.
However, increasing research and development expenditure
by the major players, universities and research hospitals, strategic alliance
among the major companies, new product development may bring the global
multiple sclerosis treatment market an opportunity to propel in the upcoming period.
In March 2019, the USFDA approved Mayzent (siponimod) tables to treat patients
with relapsing form of multiple sclerosis.
Segment Covered:
This market
intelligence report on the global multiple sclerosis treatment market encompasses
market segments based on drug type, distribution channel and geography. On the
basis of product, the sub-market is segmented into siponimod, ponesimod,
ozanimod, Ofatumumab, Ublituximab and others (including Gocovri etc.) Based on distribution
channel, the global multiple sclerosis
treatment market has been segregated into hospital pharmacies, retail
pharmacies and drug stores and e-pharmacies. By Geography, the global Multiple Sclerosis Treatment market has been divided into North America
(the U.S., Canada), Latin America (Brazil, Mexico, Argentina and other
countries), Europe (Germany, France, the U.K., Spain, Italy, Russia, and other
countries), Asia Pacific (India, Japan, China, Australia and New Zealand and
other countries), Middle East and Africa (GCC, South Africa, Israel and Other
countries).
Profiling of Market
Players:
This business
intelligence report offers profiling of reputed companies that are operating in
the market. Companies such as Novartis, Johnson and Johnson Services, Inc.,
Celegne, TG Therapeutics, Alkermis Plc., Adamas Pharmaceuticals, Merck KgaA and
others have been profiled into detail so as to offer a glimpse of the market
leaders. Moreover, parameters such as multiple sclerosis treatment market
related investment & spending and developments by major players of the
market are tracked in this global report.
Report Highlights:
In-depth
analysis of the micro and macro indicators, market trends, and forecasts of
demand is offered by this business intelligence report. Furthermore, the report
offers a vivid picture of the factors that are steering and restraining the
growth of this market across all geographical segments. In addition to that, IGR-Growth
Matrix analysis is also provided in the report so as to share insight of the
investment areas that new or existing market players can take into consideration.
Various analytical tools such as DRO analysis, Porter's five forces analysis
has been used in this report to present a clear picture of the market. The
study focuses on the present market trends and provides market forecast from
the year 2017-2027. Emerging trends that would shape the market demand in the
years to come have been highlighted in this report. A competitive analysis in
each of the geographical segments gives an insight into market share of the
global players.
Salient Features:
Ø
This study offers
comprehensive yet detailed analysis of the multiple
sclerosis treatment market, size of the
market (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the period of
forecast: 2019 – 2027, taking into account 2018 as the base year
Ø
It explains upcoming
revenue opportunities across various market segments and attractive matrix of
investment proposition for the said market
Ø
This market
intelligence report also offers pivotal insights about various market opportunities,
restraints, drivers, launch of new products, competitive market strategies of
leading market players, emerging market trends, and regional outlook
Ø
Profiling of
key market players in the world multiple
sclerosis treatment market is done by
taking into account various parameters such as company strategies, distribution
strategies, product portfolio, financial performance, key developments,
geographical presence, and company overview
Ø
Leading
market players covered this report comprise names such as. Novartis, Johnson and Johnson Services, Inc., Celegne, TG
Therapeutics, Alkermis Plc., Adamas Pharmaceuticals, Merck KgaA and among others
Ø
The data of
this report would allow management authorities and marketers of companies alike
to take informed decision when it comes to launch of products, government
initiatives, marketing tactics and expansion, and technical up gradation
Ø
The world
market for multiple sclerosis treatment market caters to the needs of various stakeholders pertaining to
this industry, namely suppliers, manufacturers, investors, and distributors for
multiple
sclerosis treatment market. The research
also caters to the rising needs of consulting and research firms, financial
analysts, and new market entrants
Ø
Research
methodologies that have been adopted for the purpose of this study have been
clearly elaborated so as to facilitate better understanding of the reports
Ø
Reports have
been made based on the guidelines as mandated by General Data Protection
Regulation
Ø
Ample number
of examples and case studies have been taken into consideration before coming
to a conclusion
Reasons to buy:
v
Identify
opportunities and plan strategies by having a strong understanding of the
investment opportunities in the Multiple Sclerosis Treatment market
v
Identification
of key factors driving investment opportunities in the Multiple Sclerosis Treatment market
v
Facilitate
decision-making based on strong historic and forecast data
v
Position
yourself to gain the maximum advantage of the industry’s growth potential
v
Develop
strategies based on the latest regulatory events
v
Identify key
partners and business development avenues
v
Respond to
your competitors’ business structure, strategy and prospects
v
Identify key
strengths and weaknesses of important market participants